The coordinated selling by multiple large holders suggests a shared negative thesis. Monitor for upcoming catalyst (e.g., pipeline data, regulatory decision) that may have precipitated this flight. The stock could face further pressure if additional institutional sales follow.
ACAD drugs
ACAD drug pipeline →How the stock moved after the report
BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 11 $21.39entry
- T+1 · 5mo ago −1.40%α −1.94% · $21.09
- T+5 · 5mo ago +0.98%α +0.55% · $21.60
- T+20 · 4mo ago +23.47%α +21.58% · $26.41
- T+60 · 2mo ago +31.00%α +26.60% · $28.02
How similar events traded
Executive Summary
A bearish institutional cluster emerged in ACAD during Q3 2025: 5 major sellers reduced holdings by ~$192.7M while only 2 buyers added $14.3M. Notable full exits from Norges Bank and near-exits from Citadel and Point72 suggest broad-based negative sentiment.
Key Financial Metrics
Institutional Positions
Net institutional flow: -$164.3M
▲ Buyers (2)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Fidelity | DOUBLED | +293.1% | $14.2M | $10.6M |
| Two Sigma | ADD | +37.8% | $14.2M | $3.8M |
▼ Sellers (5)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Norges Bank | EXIT | -100% | $31.7M | -$31.7M |
| Morgan Stanley | TRIM | -71.1% | $88.7M | -$63.3M |
| Citadel | NEAR_EXIT | -89.3% | $65.0M | -$58.1M |
| Point72 | TRIM | -53.1% | $68.4M | -$36.7M |
| Ubs Am, A Distinct Business Un | TRIM | -38.4% | $7.4M | -$2.9M |
Key Facts
- Net institutional selling of ~$192.7M vs buying of $14.3M
- Norges Bank fully exited a $31.7M position
- Morgan Stanley cut 71.1% of its stake ($63.3M sold)
- Citadel reduced 89.3% ($58.1M sold), Point72 trimmed 53.1% ($36.7M sold)
- Fidelity doubled its position to $14.2M, Two Sigma added 37.8% to $14.2M
Financial Impact
2 buyers adding $14.3M vs 5 sellers offloading $192.7M, net institutional outflow of ~$178.3M
Risk Factors
- Continued institutional selling pressure
- Potential negative fundamental catalyst (e.g., trial failure, regulatory setback)
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-ACAD-2025-Q3 |
Track record
14 reports on ACAD
1 of 3 bullish or bearish reports moved the stock their way by T+20. Best: +5.01% at T+20 after the May 6, 2026 report. 1 of 4 went positive at some point.
Filters
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $18.28 settles Dec 9
- Nov 4, 202612d ago 8-K Bullish 6/10 Entry $21.24 settles Dec 4
- Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $20.57 settles Dec 2
- Oct 23, 202624d ago 8-K Neutral 3/10 Entry $19.74 settles Nov 23
- Sep 24, 20267w ago 8-K Bullish 6/10 Entry $20.68 to $19.73 ▼ −4.59% −3.12% vs SPY
- Sep 11, 20269w ago 8-K Neutral 3/10 Entry $27.52 to $19.41 ▼ −29.47% −31.73% vs SPY
- Aug 16, 202613w ago Institutional Cluster Mixed 5/10 Entry $29.01 to $26.76 ▼ −7.76% −5.78% vs SPY
- Aug 7, 202614w ago Insider Cluster Neutral 2/10 Entry $29.39 to $27.58 ▼ −6.16% −5.24% vs SPY
- Jun 11, 202622w ago Institutional Cluster Bearish 6/10 Viewing Entry $21.39 to $26.41 ▼ −23.47% −21.58% vs SPY
- May 6, 202627w ago 8-K Bearish 6/10 Entry $22.56 to $21.43 ▲ +5.01% +8.14% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers